Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Allart Stoop

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|August 19, 2003
Engineering of a macromolecular scaffold to develop specific protease inhibitorsA Allart Stoop, Charles S Craik
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2014
Reply: To PMID 23784528Emily M Schmidt, Marc Feldmann, A Allart Stoop
Biological Chemistry|February 26, 2010
Analysis of an engineered plasma kallikrein inhibitor and its effect on contact activationA Allart Stoop, Ravi V Joshi, Christopher T Eggers, et al.
European Journal of Immunology|July 24, 2015
Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndromeLucy C Fairclough, A Allart Stoop, Ola H Negm, et al.
Cellular Signalling|January 1, 2014
TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophagesGerhard Ruspi, Emily M Schmidt, Fiona McCann, et al.
Arthritis and Rheumatism|June 21, 2013
Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell culturesEmily M Schmidt, Marie Davies, Prafull Mistry, et al.
Plos One|September 10, 2015
Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life ExtensionLaura J Goodall, Milan Ovecka, Daniel Rycroft, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2014
Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritisFiona E McCann, Dany P Perocheau, Gerhard Ruspi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|August 19, 2003
Engineering of a macromolecular scaffold to develop specific protease inhibitorsA Allart Stoop, Charles S Craik
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2014
Reply: To PMID 23784528Emily M Schmidt, Marc Feldmann, A Allart Stoop
Biological Chemistry|February 26, 2010
Analysis of an engineered plasma kallikrein inhibitor and its effect on contact activationA Allart Stoop, Ravi V Joshi, Christopher T Eggers, et al.
European Journal of Immunology|July 24, 2015
Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndromeLucy C Fairclough, A Allart Stoop, Ola H Negm, et al.
Cellular Signalling|January 1, 2014
TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophagesGerhard Ruspi, Emily M Schmidt, Fiona McCann, et al.
Arthritis and Rheumatism|June 21, 2013
Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell culturesEmily M Schmidt, Marie Davies, Prafull Mistry, et al.
Plos One|September 10, 2015
Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life ExtensionLaura J Goodall, Milan Ovecka, Daniel Rycroft, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2014
Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritisFiona E McCann, Dany P Perocheau, Gerhard Ruspi, et al.
Pageof 1